Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06677151 · ClinicalTrials.gov registry record · NA

NPA-OSA Device Tolerability, Usability and Acclimation Clinical Study in Adult Obstructive Sleep Apnea (OSA) Patients

A NA study of Sleep Apnea, Obstructive, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
2
Study locations

NCT06677151 is a NA study of Sleep Apnea, Obstructive that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 20 participants, below the 262-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06677151, a NA study of Sleep Apnea, Obstructive, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
2
Study locations

Study Summary

This pilot study is being done to determine if the nasopharyngeal airway obstructive sleep apnea (NPA-OSA) device can be used in the treatment of OSA in adults. The researchers think that the NPA-OSA device will reduce the number of apneas.

Conditions Studied

Interventions

  • DEVICE nasopharyngeal airway obstructive sleep apnea (NPA-OSA) device

Study Locations (2)

Michigan

  • Michigan Medicine - Ann Arbor
  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-03-07
Est. Completion 2026-12
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT06677151

The ClinicalTrials.gov registry entry for NCT06677151 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 262-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (92% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sleep Apnea, Obstructive appearing as the primary indexed condition, and to 1 intervention - of which nasopharyngeal airway obstructive sleep apnea (NPA-OSA) device is the first listed.

NCT06677151 reports 2 study locations spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT06677151 about?

NCT06677151 is a clinical study titled "NPA-OSA Device Tolerability, Usability and Acclimation Clinical Study in Adult Obstructive Sleep Apnea (OSA) Patients". This pilot study is being done to determine if the nasopharyngeal airway obstructive sleep apnea (NPA-OSA) device can be used in the treatment of OSA in adults. The researchers think that the NPA-OSA device will reduce the number of apneas.

What is the current status of trial NCT06677151?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-03-07. Estimated completion is 2026-12.

What conditions does trial NCT06677151 study?

This clinical trial studies the following conditions: Sleep Apnea, Obstructive.

What interventions are being tested in trial NCT06677151?

The interventions under investigation include: nasopharyngeal airway obstructive sleep apnea (NPA-OSA) device (DEVICE).

Who is sponsoring clinical trial NCT06677151?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06677151 being conducted?

This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Apnea, Obstructive

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.